Macular Telangiectasia Type 2: A Comprehensive Review

Macular Telangiectasia Type 2: A Comprehensive Review

Kiran Chandra Kedarisetti,1 Raja Narayanan,1,2 Michael W Stewart,3 Nikitha Reddy Gurram,1 Arshad M Khanani4,5 1Anant Bajaj Retina Institute, LV Prasad Eye Institute, Hyderabad, Telangana, India; 2Indian Health Outcomes, Public Health and Economics Research Centre (IHOPE), Hyderabad, Telangana, India...

Full description

Bibliographic Details
Main Authors:	Kedarisetti KC, Narayanan R, Stewart MW, Reddy Gurram N, Khanani AM
Format:	Article
Language:	English
Published:	Dove Medical Press 2022-10-01
Series:	Clinical Ophthalmology
Subjects:	macular telangiectasia type 2 mactel cntf ciliary neurotrophic factor review article
Online Access:	https://www.dovepress.com/macular-telangiectasia-type-2-a-comprehensive-review-peer-reviewed-fulltext-article-OPTH

Similar Items

Macular telangiectasia with bilateral obliterated capillaries: a case report
by: Melika Samadi, et al.
Published: (2022-10-01)

An unusual presentation of macular telangiectasia type 2 with a large pigment deposit
by: Goel, Sugandha, et al.
Published: (2021-01-01)

Relevance of multicolor imaging, its component channels, and fundus autofluorescence in describing macular telangiectasia type-2 (MacTel) lesion characteristics
by: Kiran Chandran, et al.
Published: (2024-01-01)

Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia?
by: Aditya S Kelkar, et al.
Published: (2021-01-01)

Spectral domain OCT features in type 2 macular telangiectasia (type 2 MacTel): its relevance with clinical staging and visual acuity
by: Ramesh Venkatesh, et al.
Published: (2022-04-01)

Unraveling the mysteries of macular telangiectasia 2: the intersection of philanthropy, multimodal imaging and molecular genetics. The 2022 founders lecture of the pan American vitreoretinal society
by: Lihteh Wu
Published: (2023-11-01)

Multimodal imaging of macular telangiectasia type 2 in a pediatric patient
by: Magdy Moussa, et al.
Published: (2021-06-01)

Outcome of Off-Label AREDS 2 Supplementation for the Treatment of Macular Degeneration in Non-Proliferative Idiopathic Type 2 Macular Telangiectasia
by: Berger TA, et al.
Published: (2021-03-01)

Intravitreal Bevacizumab Treatment in Type 2 Idiopathic Macular Telangiectasia
by: Tuğba Aydoğan, et al.
Published: (2016-12-01)

A complete clinical review of idiopathic macular telangiectasia
by: P Jayasri, et al.
Published: (2023-01-01)

Autologous neurosensory retinal flap for closure of refractory macular hole in a patient with macular telangiectasia
by: Andrew Hewson, et al.
Published: (2020-06-01)

Type-3 macular neovascularization in a case of long-standing macular telangiectasia type-2
by: Kiran Chandran, et al.
Published: (2023-01-01)

Distribution of macular pigments in macular telangiectasia type 2 and correlation with optical coherence tomography characteristics and visual acuity
by: Ramyaa Srinivasan, et al.
Published: (2022-06-01)

Clinical features of macular telangiectasia type 2 and comparison of staging system in Taiwanese patients
by: Yan-Yu Chen, et al.
Published: (2023-01-01)

Baseline demographic, clinical and multimodal imaging features of young patients with type 2 macular telangiectasia
by: Nikitha Gurram Reddy, et al.
Published: (2023-08-01)

Clinical Features of Untreated Type 2 Macular Telangiectasia and Efficacy of Anti-Vascular Endothelial Growth Factor Therapy in Macular Neovascularization
by: Müge Çoban Karataş, et al.
Published: (2022-02-01)

Macular Telangiectasia Type 2
by: Emily Y. Chew, MD, et al.
Published: (2023-06-01)

Management of Idiopathic Macular Telangiectasia Type 2
by: Alireza Khodabande, et al.
Published: (2019-02-01)

Structural-vascular-functional correlation in type 2 non-proliferative macular telangiectasia
by: Ramesh Venkatesh, et al.
Published: (2022-08-01)

Specific Deoxyceramide Species Correlate with Expression of Macular Telangiectasia Type 2 (MacTel2) in a SPTLC2 Carrier HSAN1 Family
by: Lindsey M. Q. Wilson, et al.
Published: (2023-04-01)

Visual acuity after cataract surgery in Macular Telangiectasia Type 2 Stage 3 to 5
by: Jacob S. Heng, et al.
Published: (2022-06-01)

Intraretinal and subretinal fluid in exudative nonproliferative macular telangiectasia type 2
by: George J Manayath, et al.
Published: (2022-01-01)

Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice
by: Wei Wei, et al.
Published: (2020-08-01)

Long-term follow-up in macular telangiectasia type 1: Clinical image
by: Juliana A Rio, et al.
Published: (2024-01-01)

Case report: internal limiting membrane drape sign masking by foveal detachment in macular telangiectasia type 2
by: Anmar Abdul-Rahman
Published: (2020-06-01)

Optic Coherence Angiography Findings in Type-2 Macular Telangiectasia
by: Hilal Nalcı, et al.
Published: (2017-12-01)

Gene therapy for Huntington's disease
by: Shilpa Ramaswamy, et al.
Published: (2012-11-01)

Tamoxifen Use in a Patient with Idiopathic Macular Telangiectasia Type 2
by: Alice Behrens, et al.
Published: (2018-01-01)

Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2
by: John Moir, et al.
Published: (2022-07-01)

Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease
by: Syed Faraz Kazim, et al.
Published: (2014-11-01)

Multicolour imaging signatures to diagnose concurrent macular telangiectasia type 2 and macular branch retinal vein occlusion
by: Schouten, Ike, et al.
Published: (2019-11-01)

Idiopathic Macular Telangiectasia Type 1 treated with Intravitreal Ranibizumab and Laser Photocoagulation
by: Inês Martins de Almeida, et al.
Published: (2015-09-01)

Refractive error as a risk factor in patients with Macular Telangiectasia type 2A: A case-control study
by: Anna Elias, et al.
Published: (2016-01-01)

Improvements in visual acuity and macular morphology following cessation of anti-estrogen drugs in a patient with anti-estrogen maculopathy resembling macular telangiectasia type 2: a pathogenic hypothesis
by: Akihiro Shinkai, et al.
Published: (2019-12-01)

Neurotrophic factors in the physiology of motor neurons and their role in the pathobiology and therapeutic approach to amyotrophic lateral sclerosis
by: Wesley M. Stansberry, et al.
Published: (2023-08-01)

Proximal nailfold videocapillaroscopy findings of patients with idiopathic macular telangiectasia type 2
by: Birumut Gedik, et al.
Published: (2024-01-01)

OCT and OCT Angiography Update: Clinical Application to Age-Related Macular Degeneration, Central Serous Chorioretinopathy, Macular Telangiectasia, and Diabetic Retinopathy
by: Lyvia Zhang, et al.
Published: (2023-01-01)

Conjunctival Telangiectasia in a Patient with Ataxia Telangiectasia: A Case Report
by: Özge Pınar Akarsu, et al.
Published: (2012-01-01)

Sight threatening diabetic retinopathy in patients with macular telangiectasia type 2
by: Josef Huemer, et al.
Published: (2024-03-01)

Transcriptional and Distributional Profiling of Microglia in Retinal Angiomatous Proliferation
by: Anja Schlecht, et al.
Published: (2022-03-01)